Global Synthetic Biology in Medical Market Growth (Status and Outlook) 2023-2029

Global Synthetic Biology in Medical Market Growth (Status and Outlook) 2023-2029

LPI (LP Information)' newest research report, the “Synthetic Biology in Medical Industry Forecast” looks at past sales and reviews total world Synthetic Biology in Medical sales in 2022, providing a comprehensive analysis by region and market sector of projected Synthetic Biology in Medical sales for 2023 through 2029. With Synthetic Biology in Medical sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Synthetic Biology in Medical industry.

This Insight Report provides a comprehensive analysis of the global Synthetic Biology in Medical landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Synthetic Biology in Medical portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Synthetic Biology in Medical market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Synthetic Biology in Medical and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Synthetic Biology in Medical.

The global Synthetic Biology in Medical market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Synthetic Biology in Medical is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Synthetic Biology in Medical is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Synthetic Biology in Medical is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Synthetic Biology in Medical players cover Thermo Fisher Scientific, Novozymes, Merck KGaA, Agilent Technologies, Arzeda, Codexis, Ginkgo Bioworks, Precigen and Genscript Biotech Corp, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Synthetic Biology in Medical market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Genome Engineering
NGS
Cloning and Sequencing

Segmentation by application
Drug Discovery And Therapeutics
Pharmaceuticals
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Novozymes
Merck KGaA
Agilent Technologies
Arzeda
Codexis
Ginkgo Bioworks
Precigen
Genscript Biotech Corp
TeselaGen
Integrated DNA Technologies
Twist Bioscience
New England Biolabs

Please note: The report will take approximately 2 business days to prepare and deliver.